Invacare 2008 Annual Report Download - page 22

AVAILABLE INFORMATION
The company files Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on
Form 8-K, and any amendments thereto, as well as proxy statements and other documents with the Securities and
Exchange Commission (SEC). The public may read and copy any material that the company files with the SEC at
the SEC’s Public Reference Room located at 100 F Street, NE, Washington D.C. 20549. The public may obtain
information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC
also maintains a website, www.sec.gov, which contains all reports, proxy statements and other information filed
by the company with the SEC.
Additionally, Invacare’s filings with the SEC are available on or through the company’s website,
www.invacare.com, as soon as reasonably practicable after they are filed electronically with, or furnished to, the
SEC. Copies of the company’s filings also can be requested, free of charge, by writing to: Shareholder Relations
Department, Invacare Corporation, One Invacare Way, P.O. Box 4028, Elyria, OH 44036-2125.
FORWARD-LOOKING INFORMATION
This Form 10-K contains forward-looking statements within the meaning of the “Safe Harbor” provisions
of the Private Securities Litigation Reform Act of 1995. Terms such as “will,” “should,” “plan,” “intend,”
“expect,” “continue,” “forecast,” “believe,” “anticipate” and “seek,” as well as similar comments, are
forward-looking in nature. Actual results and events may differ significantly from those expressed or anticipated
as a result of risks and uncertainties which include, but are not limited to, the following: possible adverse effects
of being substantially leveraged, which could impact our ability to raise capital, limit our ability to react to
changes in the economy or our industry or expose us to interest rate or event of default risks; adverse changes in
government and other third-party payor reimbursement levels and practices; consolidation of health care
providers and our competitors; loss of key health care providers; ineffective cost reduction and restructuring
efforts; inability to design, manufacture, distribute and achieve market acceptance of new products with higher
functionality and lower costs; extensive government regulation of our products; lower cost imports; increased
freight costs; failure to comply with regulatory requirements or receive regulatory clearance or approval for our
products or operations in the United States or abroad; potential product recalls; uncollectible accounts
receivable; the uncertain impact on our providers, on our suppliers and on the demand for our products of the
recent global economic downturn and general volatility in the credit and stock markets; difficulties in
implementing an Enterprise Resource Planning system; legal actions or regulatory proceedings and
governmental investigations; product liability claims; inadequate patents or other intellectual property
protection; incorrect assumptions concerning demographic trends that impact the market for our products;
provisions of Ohio law or in our debt agreements, our shareholder rights plan or our charter documents that
may prevent or delay a change in control; the loss of the services of our key management and personnel;
decreased availability or increased costs of raw materials which could increase our costs of producing our
products; inability to acquire strategic acquisition candidates because of limited financing alternatives; risks
inherent in managing and operating businesses in many different foreign jurisdictions; increased security
concerns and potential business interruption risks associated with political and/or social unrest in foreign
countries where the company’s facilities or assets are located; exchange rate and tax rate fluctuations, as well as
the risks described from time to time in Invacare’s reports as filed with the Securities and Exchange Commission.
Except to the extent required by law, we do not undertake and specifically decline any obligation to review or
update any forward-looking statements or to publicly announce the results of any revisions to any of such
statements to reflect future events or developments or otherwise.
I-16